Literature DB >> 1404125

IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases.

J J Wisnieski1, S M Jones.   

Abstract

We previously found that the Clq precipitin in sera from patients with hypocomplementemic urticarial vasculitis syndrome is an IgG autoantibody to Clq. We report here a prevalence study of this autoantibody in 162 patients with musculoskeletal or rheumatic diseases including hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus (SLE), and rheumatoid arthritis uncomplicated by vasculitis. The autoantibody, which binds only to the collagen-like region of Clq, was found almost exclusively in hypocomplementemic urticarial vasculitis syndrome (100%) and SLE (35%) sera. Our results support the idea that among rheumatic diseases, anti-Clq autoantibody develops in disorders characterized by immune complex mediated injury, particularly of cutaneous and glomerular microvasculature.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1404125

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  20 in total

Review 1.  Autoantibodies against C1q: view on clinical relevance and pathogenic role.

Authors:  C E Siegert; M D Kazatchkine; A Sjöholm; R Würzner; M Loos; M R Daha
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  MacDuffie syndrome and primary sclerosing cholangitis: an exceptional association.

Authors:  Xavier Roblin; Jean-Marc Phelip; Marie Noelle Hilleret; Nathalie Sturm; Frederic Heluwaert; Bruno Bonaz; Jean-Pierre Zarski
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

Review 3.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

4.  Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.

Authors:  Heikki Julkunen; Susanne Ekblom-Kullberg; Aaro Miettinen
Journal:  Rheumatol Int       Date:  2011-06-26       Impact factor: 2.631

5.  Hypocomplementemic Urticarial Vasculitis Syndrome in an 8-year-old Boy: A Case Report and Review of Literature.

Authors:  Zakiya Saleh Adnan Al Mosawi; Badriya Ebrahim Ahmed Al Hermi
Journal:  Oman Med J       Date:  2013-07

Review 6.  Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge.

Authors:  Wolfgang Grotz; Hideo A Baba; Jan U Becker; Martin W Baumgärtel
Journal:  Dtsch Arztebl Int       Date:  2009-11-13       Impact factor: 5.594

Review 7.  Urticarial vasculitis.

Authors:  Joe Venzor; Wai L Lee; David P Huston
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

8.  Hypocomplementaemic urticarial vasculitis syndrome: a mimicker of systemic lupus erythematosus.

Authors:  Krishnendu Roy; Arunansu Talukdar; Bappaditya Kumar; Sumanta Sarkar
Journal:  BMJ Case Rep       Date:  2013-05-22

9.  Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.

Authors:  N Marto; M L Bertolaccini; E Calabuig; G R V Hughes; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

10.  Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease.

Authors:  E Potlukova; J Jiskra; Z Limanova; P Kralikova; D Smutek; H Mareckova; M Antosova; M Trendelenburg
Journal:  Clin Exp Immunol       Date:  2008-05-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.